Quantitative analysis for Achieve Life Sciences, Inc. (ACHV) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (64.0) (grade B). Gem alpha score: 42.0. 33 signals analyzed (27 differentiated alt-data).
ACHV stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-30 | $4.41 | $4.18 | $4.39 |
| 2026-05-12 | $6.15 | $5.35 | $5.99 |
| 2026-05-22 | $4.81 | $4.62 | $4.69 |
| 2026-06-04 | $5.50 | $4.88 | $5.29 |
| 2026-06-16 | $5.75 | $5.42 | $5.55 |
| 2026-06-29 | $6.31 | $5.97 | $6.23 |
| 2026-07-10 | $6.40 | $5.81 | $6.11 |
| 2026-07-22 | $6.64 | $6.28 | $6.31 |
| 2026-08-03 | $6.50 | $6.20 | $6.32 |
| 2026-08-13 | $7.34 | $6.84 | $7.25 |
| 2026-08-25 | $8.42 | $8.01 | $8.17 |
| 2026-09-04 | $8.56 | $8.10 | $8.49 |
How Achieve Life Sciences, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| PMI | Picard Medical, Inc. | $240M | — |
| SENS | Senseonics Holdings, Inc. | $239M | — |
| PRLD | Prelude Therapeutics Incorporated | $251M | — |
| CGEN | Compugen Ltd. | $256M | — |
View all Health Care stocks by valuation and signals →
Achieve Life Sciences, Inc. (ACHV) scores Buy (64.0), and the composite conceals a 98-point disagreement between its dimensions. It is strongest on ML forecast at 98 and technicals at 73, and weakest on competitive moat at 1 and analyst consensus at 0. A stock can carry ML forecast that high while analyst consensus sits at 0; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 98 |
| technicals | 73 |
| valuation | 72 |
| earnings quality | 67 |
| social sentiment | 22 |
| AI Alpha (gem) | 7 |
| competitive moat | 1 |
| analyst consensus | 0 |
StoQuant analyzes 33 signals (27 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Achieve Life Sciences, Inc. (ACHV): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/ACHV"><img src="https://stoquant.com/badge/ACHV.svg" alt="Achieve Life Sciences, Inc. (ACHV) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.